Ecofibre Ltd (ASX: EOF) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ecofibre Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $351.25 million
P/E Ratio 400.00
Dividend Yield N/A
Shares Outstanding 341.02 million
Earnings per share 0.003
Dividend per share N/A
Year To Date Return -46.98%
Earnings Yield 0.25%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

EOF ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Ecofibre Ltd

Ecofibre Ltd through its subsidiaries is engaged in three business lines including Ananda Health, Ananda Food and Hemp Black. Amanda Health includes Production and sale of hemp related nutraceutical products focused on the US. Ananda Food includes Production and sale of hemp related food products in Australia. Hemp Black includes the development of hemp related fibreproducts globally.

EOF Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
11 Jun 2021 $1.01 $-0.03 -2.88% 133,027 $1.02 $1.05 $0.98
10 Jun 2021 $1.04 $-0.03 -2.79% 621,496 $1.08 $1.20 $1.00
09 Jun 2021 $1.08 $0.21 24.14% 575,024 $0.89 $1.09 $0.88
08 Jun 2021 $0.87 $-0.01 -1.14% 118,134 $0.89 $0.92 $0.86
07 Jun 2021 $0.88 $-0.01 -1.12% 506,241 $0.92 $0.93 $0.85
04 Jun 2021 $0.89 $0.15 20.27% 697,059 $0.74 $0.90 $0.72
03 Jun 2021 $0.74 $0.15 25.21% 700,821 $0.63 $0.74 $0.60
02 Jun 2021 $0.60 $0.05 9.17% 269,711 $0.56 $0.60 $0.55
01 Jun 2021 $0.55 $-0.01 -1.82% 332,225 $0.54 $0.56 $0.54
31 May 2021 $0.55 $0.00 0.00% 399,434 $0.55 $0.56 $0.53
28 May 2021 $0.55 $-0.01 -1.79% 682,248 $0.53 $0.57 $0.53
27 May 2021 $0.56 $0.04 7.69% 4,583,904 $0.56 $0.60 $0.53
26 May 2021 $0.52 $0.05 10.53% 1,389,194 $0.49 $0.58 $0.48
25 May 2021 $0.48 $-0.02 -4.04% 1,395,613 $0.51 $0.54 $0.48
24 May 2021 $0.50 $-0.09 -15.52% 1,518,656 $0.57 $0.57 $0.50
21 May 2021 $0.58 $0.02 3.54% 806,470 $0.61 $0.65 $0.56
20 May 2021 $0.57 $-0.06 -9.68% 1,280,872 $0.63 $0.64 $0.56
19 May 2021 $0.62 $-0.03 -4.62% 554,873 $0.66 $0.68 $0.62
18 May 2021 $0.65 $0.00 0.00% 782,058 $0.67 $0.72 $0.64
17 May 2021 $0.65 $-0.07 -9.79% 655,937 $0.72 $0.74 $0.65

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
11 Dec 2020 Eric Tse Wang Buy 350 $745,182
On-market trade.
21 Aug 2020 Barry Lambert Sell 51 $143,371
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Barry Martin Lambert Non-Executive ChairmanNon-Executive Director Oct 2017
Mr Lambert was also asked to serve as Chairman of Class Limited and subsequently took Class through to listing on the ASX. Barry founded ASX listed company, Count Limited in 1980. In 2016 and 2017, Barry and Joy Lambert made donations to establish the Lambert Initiative at Sydney University and Lambert Center at Thomas Jefferson University, respectively. Both entities are focused on the research and education of medicinal cannabis and hemp. In 2017, Barry resigned as Chairman of Class Limited.
Professor Bruce Gregory Robinson Non-Executive Director Mar 2021
Prof Robinson has over 25 years leadership experience as a board director, academic physician and scientist across research, healthcare and medicine, and tertiary education. He has experience covering academia, government, public and private health providers, research institutes and philanthropic organisations. He is currently a director of Cochlear, an ASX listed global hearing implants business; MaynePharma, an ASX listed pharmaceutical manufacturer; and QBiotics, a drug development company. Since 2015 Prof Robinson has also chaired the Australian Government's National Health and Medical Research Council, and the Medical Benefits Schedule Review Task Force. His prior professional experience includes Dean of University of Sydney's Sydney Medical School, Head of Medicine at Sydney's Royal North Shore Hospital and Head of the Cancer Genetics Laboratory at the Kolling Institute for Medical Research. The summary of his experience is as follows: 2015 - present: Chair of the National Health and Medical Research Council; 2015 - present: Chair of the Medical Benefits Schedule Review Taskforce; 2007 - 2016: Dean, Sydney Medical School; 1998 - 2006: Head, Division of Medicine, Royal North Shore Hospital; 1990 - 2008: Head, Cancer Genetics Laboratory, Kolling Institute for Medical Research. Boards experience includes : Cochlear, 2015 - present; QBiotics, 2015 - present; MaynePharma, 2014 - present; and Woolcock Institute, 2006 - present
Mr Jonathan (Jon) Peter Meadmore Non-Executive Director Oct 2017
Mr Meadmore is a Brisbane-based partner of law firm, Colin Biggers & Paisley. He is the joint leader of the corporate group, having practiced law for over 25 years.
Mr Eric Tse Wang Chief Executive OfficerManaging Director Nov 2015
Mr Wang has over 25 years of leadership and executive management experience, both as an officer in the United States Army and as a financial services executive in Australia. Prior to joining Ecofibre, Eric served as Captain and Apache pilot in the US Army for eight years in a range of roles, including Troop Commander, Operations Officer, Executive Officer and Personnel Officer in the United States and Europe.
Ms Kristi Woolrych Non-Executive Director Oct 2020
Ms Woolrych has over 20 years' experience in brand strategy, acquisition, retention, customer experience, eCommerce and retail marketing in a various of industries. She is currently the Chief Marketing Officer for KFC in Australia and New Zealand. Her experience include at KFC across the last two years and brand performance, resulting in APAC Effie Awards for Brand of the Year and Marketing Team of the Year in 2020. Prior to KFC, Ms Woolrych worked at Suncorp for over a decade, where she was promoted to the position of Executive General Manager, Brand and Marketing. During her carree she holds following position: 2018-Present Chief Marketing Officer, KFC SOPAC; 2016-2018 Executive General Manager Brand and Marketing, Suncorp; 2015-2016 Executive General Manager Group Marketing, Suncorp; 2013-2015 Executive Manager Brand and Customer Strategy, Suncorp; 2010-2013 Executive Manager Strategic Marketing and Insights, Suncorp; 2007-2010 Executive Manager Digital Marketing, Suncorp; and Other Experience MojoPartners (Publicis); Clemenger BBDO. She has completed a range of postgraduate programs including the Harvard Business School Digital Masterclass, INSEAD CMO Academy and Australian Marketing Institute Advanced Strategic Planning.
Mr Jonathan Cedric Mengel Brown Chief Financial OfficerJoint Company Secretary Jan 2021
-
Ms Robin Sheldon General CounselJoint Company Secretary Jan 2021
-
Jonathan Cedric Mengel Brown Chief Financial OfficerJoint Company Secretary
-
Robin Sheldon General CounselJoint Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 26,664,201 8.00%
Thomas Jefferson University 10,532,143 3.16%
Pacific Custodians Pty Limited 8,016,536 2.40%
Texsymmetry Inc 6,454,890 1.94%
Citicorp Nominees Pty Limited 5,316,294 1.59%
John Ryan 5,099,289 1.53%
Jp Morgan Nominees Australia Pty Limited 4,406,508 1.32%
Barjoy Pty Ltd 3,994,976 1.20%
Barry Martin Lambert & Joy Wilma Lillian Lambert 3,218,975 0.97%
Profitous Pty Ltd 2,946,288 0.88%
Troncell Pty Ltd 2,922,078 0.88%
National Nominees Limited 2,032,896 0.61%
James 1916 Pty Ltd 2,000,000 0.60%
Phildew Pty Ltd 1,948,053 0.58%
Yarrawonga Holdings Pty Ltd 1,616,606 0.48%
Yarrawonga Holdings Pty Limited 1,601,494 0.48%
Miranda June Brown 1,364,998 0.41%
Brian Furnish & Amy Furnish 1,130,191 0.34%
E G Enterprises Pty Ltd 1,101,364 0.33%
William David Furnish 1,035,793 0.31%

Profile

since

Note